Control Bionics Limited (ASX: CBL)
Australia
· Delayed Price · Currency is AUD 0.0610
0.00 (0.00%)
Dec 24, 2024, 12:15 PM AEST
Control Bionics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2018 |
| Operating Revenue | 5.35 | 5.35 | 5.64 | 4.5 | 3.97 | 3.1 | Upgrade
|
| Other Revenue | - | - | - | - | 0.12 | 0.1 | Upgrade
|
| Revenue | 5.35 | 5.35 | 5.64 | 4.5 | 4.09 | 3.2 | Upgrade
|
| Revenue Growth (YoY) | -5.17% | -5.17% | 25.33% | 10.11% | 27.68% | 257.25% | Upgrade
|
| Cost of Revenue | 1.45 | 1.45 | 1.93 | 1.99 | 1.43 | 0.71 | Upgrade
|
| Gross Profit | 3.9 | 3.9 | 3.71 | 2.51 | 2.66 | 2.49 | Upgrade
|
| Selling, General & Admin | 7.7 | 7.7 | 8.45 | 8.12 | 5.44 | 3.4 | Upgrade
|
| Research & Development | 1.71 | 1.71 | 0.23 | 0.32 | 0.17 | 0.07 | Upgrade
|
| Other Operating Expenses | -0.89 | -0.89 | -0.45 | -0.35 | - | - | Upgrade
|
| Operating Expenses | 9.78 | 9.78 | 8.95 | 8.68 | 5.81 | 3.59 | Upgrade
|
| Operating Income | -5.88 | -5.88 | -5.24 | -6.18 | -3.15 | -1.1 | Upgrade
|
| Interest Expense | -0.06 | -0.06 | -0.02 | -0.01 | -0.07 | -0 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.02 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0 | -0 | 0.03 | 0.1 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0.03 | -0.78 | - | Upgrade
|
| EBT Excluding Unusual Items | -5.92 | -5.92 | -5.24 | -6.19 | -3.89 | -1.1 | Upgrade
|
| Other Unusual Items | 0.01 | 0.01 | -0.39 | 0.09 | 0.34 | 0.1 | Upgrade
|
| Pretax Income | -5.91 | -5.91 | -5.63 | -6.1 | -3.55 | -1.01 | Upgrade
|
| Net Income | -5.91 | -5.91 | -5.63 | -6.1 | -3.55 | -1.01 | Upgrade
|
| Net Income to Common | -5.91 | -5.91 | -5.63 | -6.1 | -3.55 | -1.01 | Upgrade
|
| Shares Outstanding (Basic) | 159 | 159 | 90 | 85 | 63 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 159 | 159 | 90 | 85 | 63 | 10 | Upgrade
|
| Shares Change (YoY) | 76.64% | 76.64% | 5.80% | 36.04% | 535.65% | 4.93% | Upgrade
|
| EPS (Basic) | -0.04 | -0.04 | -0.06 | -0.07 | -0.06 | -0.10 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.04 | -0.06 | -0.07 | -0.06 | -0.10 | Upgrade
|
| Free Cash Flow | -5.31 | -5.31 | -4.96 | -7.03 | -4.04 | -1.16 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.05 | -0.08 | -0.06 | -0.12 | Upgrade
|
| Gross Margin | 72.82% | 72.82% | 65.78% | 55.69% | 65.02% | 77.69% | Upgrade
|
| Operating Margin | -109.92% | -109.92% | -92.78% | -137.19% | -77.01% | -34.31% | Upgrade
|
| Profit Margin | -110.52% | -110.52% | -99.80% | -135.53% | -86.85% | -31.40% | Upgrade
|
| Free Cash Flow Margin | -99.24% | -99.24% | -87.84% | -156.26% | -98.79% | -36.19% | Upgrade
|
| EBITDA | -5.16 | -5.16 | -4.87 | -5.76 | -3 | -1.01 | Upgrade
|
| EBITDA Margin | -96.40% | -96.40% | -86.31% | -127.93% | -73.28% | -31.57% | Upgrade
|
| D&A For EBITDA | 0.72 | 0.72 | 0.37 | 0.42 | 0.15 | 0.09 | Upgrade
|
| EBIT | -5.88 | -5.88 | -5.24 | -6.18 | -3.15 | -1.1 | Upgrade
|
| EBIT Margin | -109.92% | -109.92% | -92.78% | -137.19% | -77.01% | -34.31% | Upgrade
|
| Revenue as Reported | 6.36 | 6.36 | 6.11 | 4.94 | 4.43 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.